Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT
NCT03531437 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 112
Last updated 2018-05-21
Summary
The purpose of this study is to compare the effects of Zoely® and Minidoz® on hemostatic profiles
Conditions
- Contraception
- Hypercoagulability
Interventions
- DRUG
-
1.5 mg estradiol and 2.5 mg nomegestrol acetate
- DRUG
-
15 µg ethinylestradiol and 60 µg gestodene
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2018-01-31
- Completion
- 2018-04-18
More Related Trials
-
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
NCT00651846 ·Status: COMPLETED ·Phase: PHASE4
-
Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)
NCT00511355 ·Status: COMPLETED ·Phase: PHASE3
-
Birth Control Pill vs Birth Control Patch Study
NCT00554632 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
NCT00212342 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01252186 ·Status: COMPLETED ·Phase: PHASE2
-
Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives
NCT07071389 ·Status: WITHDRAWN ·Phase: NA
-
Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters
NCT00318799 ·Status: COMPLETED ·Phase: PHASE2
-
Norethindrone for the Delay of Menstruation
NCT03594604 ·Status: COMPLETED ·Phase: PHASE4
-
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
NCT07083635 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)
NCT00413062 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
NCT00344383 ·Status: COMPLETED ·Phase: PHASE2
-
Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
NCT01482338 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)
NCT00511199 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant
NCT04047875 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Combined Oral Contraceptive Effects in Female Subjects
NCT02157467 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
NCT01953809 ·Status: WITHDRAWN ·Phase: PHASE1
-
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
NCT01963403 ·Status: TERMINATED ·Phase: PHASE4
-
Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception
NCT03077555 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
NCT00128726 ·Status: COMPLETED
-
Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB
NCT02103764 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones
NCT00556400 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
NCT00709644 ·Status: COMPLETED ·Phase: PHASE1
-
DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
NCT01148420 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
NCT01638923 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00932321 ·Status: COMPLETED ·Phase: PHASE3